Search

Displaying results 7691 - 7700 of 10000 in total
  1. Drug

    Nitroaspirin

    go.drugbank.com/drugs/DB12445
    Investigational

    Nitroaspirin has been investigated for the treatment of Intermittent Claudication.

    Categories: Non COX-2 selective NSAIDS
  2. Drug

    Mavrilimumab

    go.drugbank.com/drugs/DB12534
    Investigational

    Mavrilimumab has been investigated for the treatment of Rheumatoid Arthritis.

  3. Drug

    AC-430

    go.drugbank.com/drugs/DB12535
    Investigational

    AC430 has been investigated for the treatment of Rheumatoid Arthritis.

  4. Drug

    Tocotrienol

    go.drugbank.com/drugs/DB12647
    Investigational

    Tocotrienol has been investigated for the treatment of Cholesterol Lowering.

    Mixtures: NHF Tocotrienol E Plus Vitamin D3 SoftgelCategories: Vitamin E, Heterocyclic Compounds, 1-Ring
  5. Drug

    Bi104

    go.drugbank.com/drugs/DB18743
    Experimental

    Bi104 is being investigated for the treatment of Angelman syndrome.

  6. Drug

    BL-1020

    go.drugbank.com/drugs/DB05687
    Investigational

    BL-1020 is a first in class novel compound for the treatment of schizophrenia. It is being developed by BioLineRx (BioLine).

    Categories: Heterocyclic Compounds, 3-Ring
  7. Drug

    Nanrilkefusp alfa

    go.drugbank.com/drugs/DB17480
    Investigational

    Nanrilkefusp alfa is a human fusion protein consisting of the cytokine interleukin (IL)-15 and the high-affinity binding sushi+ domain of IL-15 receptor alpha (IL-15Ra).

  8. Drug

    BEA-17

    go.drugbank.com/drugs/DB18574
    Experimental

    BEA-17 is a small molecule targeted degrader of the epigenetic enzyme LSD1 and its co-factor CoREST.[L48330] It is under investigation for the treatment of glioblastoma.

  9. Drug

    BT200

    go.drugbank.com/drugs/DB18333
    Investigational

    [A261491] It is under investigation for the treatment of von Willebrand disease and hemophilia A.[L48156] … BT200 (Rondoraptivon pegol) is a PEGylated anti-von Willebrand factor (VWF) aptamer targeted against the VWF A1 domain.

  10. Drug

    BGT-DTDS

    go.drugbank.com/drugs/DB18664
    Experimental

    BGT-DTDS is an investigational gene therapy comprising an adeno-associated viral vector type 2 (AAV2) encoding the human _SLC6A3_ gene. … It is under investigation for the treatment of dopamine transporter deficiency syndrome (DTDS).

    Synonyms: Adeno-associated viral vector serotype 2 containing the human SLC6A3 gene